You are here

  • Home
  • Archive
  • Volume 61, Issue Suppl 2
  • PWE-250 Azathioprine and allopurinol co-therapy for IBD patients is a safe and effective treatment option in the district general hospital setting

Article info

Article menu

Download PDFPDF

Posters
Inflammatory bowel disease III
PWE-250 Azathioprine and allopurinol co-therapy for IBD patients is a safe and effective treatment option in the district general hospital setting
Free

Authors

Citation

Johnson HE, Weaver SA, McLaughlin SD
PWE-250 Azathioprine and allopurinol co-therapy for IBD patients is a safe and effective treatment option in the district general hospital setting
Gut 2012;61:A399-A400.

Publication history

  • First published May 28, 2012.
Online issue publication 
April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.